Welcome to our shared Vision 2025 for Novartis Pharma in Australia & New Zealand. The Vision 2025 was co-created with feedback from hundreds of associates, both in the field and at head office. The Vision map below will step you through how we’ll achieve our Vision statement i.e “Our exceptional people make life changing treatments available to everyone, with speed and simplicity.”
Our Pillars
Our pillars of ACCESS, ENGAGEMENT, DIGITAL & DATA and PARTNERSHIPS are underpinned by the foundational pillar of our PEOPLE.
PEOPLE: “We’re Awesome” Our people are the heart of everything we do.
1. Patients at Centre
We’re inspired and motivated to make difference for patients. Our customers sit at the interface with the patient, so we need to obsess about understanding our customers to facilitate the best outcome for patients.
Case Study
2. Patients caught in the maze
All of us would have an experience of being (or caring for) a patient at one time or another. Patients can’t wait by getting stuck or trapped in the maze of the healthcare system, particularly if this means waiting for a diagnosis.
Case Study
3. Our pipeline of transformative innovation
We transform lives with medicines that are either first in class or best in class. We have the best pipeline in the industry; for common and chronic diseases and we are leaders in Cell and Gene Therapy.
Case Study4. We want to be a launch powerhouse
In 2021 we are preparing to launch Kesimpta + Mayzent (MS), Beovu (Macular Degeneration) and Leqvio (Familial hypercholesterolemia). We also have a focused, agile launch model to bring our transformative Gene therapy pipeline to patients. We have an obligation to extend and accelerate access to our medicines. Our measure is transforming the standard of care for twice as many patients, twice as fast.
5. Internal block busting
We have to simplify and we need to break down barriers. We need to become more externally focused, curious and unbossed in our approach. At the PEC table we want to hear about your internal barriers and push down decision making so our associates are empowered to get on with their job.
6. The changing healthcare landscape
With the landscape in increasing flux (particularly as a result of COVID-19), we have the innovation and talent to play a leading role in shaping the future of healthcare and of models of access to treatment. We must win for patients, win for the healthcare professionals and win for the healthcare system i.e. The Triple Win!
Case Study7. Digital access to health data is changing patient and HCP experiences, needs and expectations
Medical information is more accessible to everyone nowadays. Digitally empowered patients are becoming more aware, health consumers and demanding better care.
Case Study
8. The stakeholder landscape is changing
We must find high value add solutions to help government provide high quality health services and manage expenditure.
9. Being curious through our engagement with patients and HCPs
Customer obsession is critical. The 2021 Big Bold Objective for the Pharma Leadership Team (PEC) is “Make customer obsession a reality in everything we do”.
Through Next Generation Engagement (NGE) we need to create deeper personalised customer connections, through co-ordinated strategies to amplify our impact and stand out from the crowd.
We must also listen to our patients, and bring their insights into the company so we can create tangible solutions that impact their lives.
Case Study
10. Brilliant at the BASICS
Executional excellence will sustain our way forward. We need to sustain our traditional business model as the value generator and platform for innovation. We will strive for speed and simplicity. We need to build on our best practices and strive to be brilliant at the basics.
Case Study
11. Innovate for broad and early access
We need to partner with patients, customers and non-traditional partners to innovate within and beyond the healthcare system.
Case Study12. Preparing for TRANSFORMATION
The healthcare landscape is poised for disruption. Strategic partnerships and agility will be fundamental to our success in the emergent healthcare environment.
Case Study
